Home  |  Sitemap  |  Contact Us  |  Translate

Lockhart Community News
COVID-19 VACCINE UPDATE: Texas State Health Dept. lifts pause on Johnson & Johnson vaccines

Over the weekend, the Texas Department of State Health Services announced vaccine providers may now continue administering the Johnson & Johnson vaccine after a thorough safety review from the CDC’s advisory committee. That committee determined the benefits outweigh the risks.


“The Johnson & Johnson vaccine is an important tool in our fight against COVID-19, and the scientific review over the last 11 days has affirmed its safety and effectiveness,” said Dr. John Hellerstedt, DSHS commissioner. “We know some Texans prefer the simplicity of a single-dose vaccine, and the ease of storing and handling this vaccine gives providers more flexibility. Resuming the use of the Johnson & Johnson vaccine will prevent hospitalizations and save lives in Texas.”



The Johnson & Johnson vaccine was paused April 13 after six patients developed blood clots, known as thrombosis with thrombocytopenia syndrome, or TTS. These cases triggered a safety review that led to the discovery of an additional nine instances of blood clots connected to the vaccine. That brought cases up to 15, out of seven million people who have received the Johnson & Johnson vaccine.  


On top of allowing the administration of the vaccine, the DSHS also shared information on how to treat  TTS. Vaccine providers were also instructed to share this fact sheet with recipients.


While TTS is extremely rare, you should seek medical attention if you experience any of these symptoms within three weeks of receiving the Johnson & Johnson vaccine:

  • Shortness of breath
  • Chest pain
  • Leg swelling
  • Persistent abdominal pain
  • Severe or persistent headaches or blurred vision
  • Easy bruising or tiny blood spots under the skin beyond the site of the injection

Copyright © 2016, City of Lockhart, TX

powered by ezTaskTitanium TM